ConductScience.org, home

Paper2848486

Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.

Snyder DB and 3 others. Avian Dis, 1988. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies. Papers, record 2848486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2848486

Download JSON
Cell line
MCA B293 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies.
PubMed
Journal
Avian Dis
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
3.59
iCite
Revised in PubMed
2006-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Snyder DBD B
2Lana DPD P
3Cho BRB R
4Marquardt WWW W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antigens, ViralMajor topic
Infectious bursal disease virusMajor topic
ReoviridaeMajor topic
Animals
Antibody Specificity
Blotting, Western
Enzyme-Linked Immunosorbent Assay
Hybridomas
Mice
Neutralization Tests

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
26502988Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.Virol J2015https://conductscience.org/library/papers/26502988PubMed
23024743Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.PLoS One2012https://conductscience.org/library/papers/23024743PubMed
17881448Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.J Virol2007https://conductscience.org/library/papers/17881448PubMed
16940532Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection.J Virol2006https://conductscience.org/library/papers/16940532PubMed
15331738A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.J Virol2004https://conductscience.org/library/papers/15331738PubMed
15222739Very virulent infectious bursal disease virus in Egypt: epidemiology, isolation and immunogenicity of classic vaccine.Vet Res Commun2004https://conductscience.org/library/papers/15222739PubMed
10074133Adaptation of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2.J Virol1999https://conductscience.org/library/papers/10074133PubMed
8856029Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.Arch Virol1996https://conductscience.org/library/papers/8856029PubMed
7832521Development of an efficient bioprocess for poultry vaccines using high-density insect cell culture.Ann N Y Acad Sci1994https://conductscience.org/library/papers/7832521PubMed
7682403Nucleotide sequence analysis of the serotype-specific epitope of infectious pancreatic necrosis virus.Arch Virol1993https://conductscience.org/library/papers/7682403PubMed
1850233Comparison of neutralizing antigens of recent isolates of infections bursal disease virus.Arch Virol1991https://conductscience.org/library/papers/1850233PubMed
1333761Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.Arch Virol1992https://conductscience.org/library/papers/1333761PubMed
1333752Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.Arch Virol1992https://conductscience.org/library/papers/1333752PubMed
1329340Genetic mechanisms of antigenic variation in infectious bursal disease virus: analysis of a naturally occurring variant virus.Virus Genes1992https://conductscience.org/library/papers/1329340PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2848486

GET https://conductscience.org/api/papers/v1/2848486/authors